Jasper Ridge Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Jasper Ridge Partners’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$731K	Hold	6,248	–	–	0.02%	102
2026 Q1	$577K	Hold	6,248	–	–	0.01%	101
2025 Q4	$494K	Sell	6,248 -1,958	-24%	-$141K	0.01%	109
2025 Q3	$602K	Hold	8,206	–	–	0.01%	101
2025 Q2	$418K	Hold	8,206	–	–	0.01%	107
2025 Q1	$370K	Hold	8,206	–	–	0.01%	108
2024 Q4	$339K	Hold	8,206	–	–	0.01%	113
2024 Q3	$320K	Hold	8,206	–	–	0.01%	112
2024 Q2	$281K	Hold	8,206	–	–	0.01%	119
2024 Q1	$206K	Sell	8,206 -17,619	-68%	-$484K	0.01%	132
2023 Q4	$762K	Buy	+25,825	New	+$782K	0.03%	91

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jasper Ridge Partners's MIRM Position: Q2 2026 in Review

Jasper Ridge Partners held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 6,248 shares worth $731K. The position accounts for 0.02% of the portfolio, ranked #102.

Jasper Ridge Partners first reported a position in MIRM in Q4 2023 and has held it in 11 quarters since. The position peaked at $762K in Q4 2023. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Jasper Ridge Partners held 6,248 shares of Mirum Pharmaceuticals worth $731K as of Q2 2026.
Jasper Ridge Partners left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
Mirum Pharmaceuticals made up 0.02% of Jasper Ridge Partners's portfolio in Q2 2026, its #102 holding.
Jasper Ridge Partners first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Jasper Ridge Partners's Mirum Pharmaceuticals position peaked at $762K in Q4 2023.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Jasper Ridge Partners's 13F filing for Q2 2026, filed 13 Aug 2026.